Impact of cranial and axillary/subclavian artery involvement by color duplex sonography on response to treatment in giant cell arteritis

被引:42
|
作者
Czihal, Michael [1 ]
Piller, Anne [1 ]
Schroettle, Angelika [1 ]
Kuhlencordt, Peter [1 ]
Bernau, Christoph [3 ,4 ]
Schulze-Koops, Hendrik [2 ]
Hoffmann, Ulrich [1 ]
机构
[1] Munich Univ Hosp, Div Vasc Med, D-80336 Munich, Germany
[2] Munich Univ Hosp, Div Rheumatol & Clin Immunol, D-80336 Munich, Germany
[3] Munich Univ Hosp, Med Clin & Policlin 4, D-80336 Munich, Germany
[4] Munich Univ Hosp, Dept Med Informat Biometry & Epidemiol, D-80336 Munich, Germany
关键词
PLACEBO-CONTROLLED TRIAL; LARGE-VESSEL INVOLVEMENT; DOUBLE-BLIND; METHOTREXATE; THERAPY; ULTRASONOGRAPHY; FEMOROPOPLITEAL; INTERLEUKIN-6; DURATION;
D O I
10.1016/j.jvs.2014.12.045
中图分类号
R61 [外科手术学];
学科分类号
摘要
Objective: Color duplex sonography (CDS) today is broadly used in the diagnostic workup of patients with suspected cranial or extracranial giant cell arteritis (GCA). This study aimed to determine the prognostic impact of the disease pattern assessed by CDS on the treatment response in GCA. Methods: This was a retrospective, longitudinal follow-up study of 43 patients who were diagnosed with GCA at our institution between 2002 and 2010. All patients underwent CDS of the temporal and subclavian/axillary arteries at baseline and were observed for at least 6 months. Vasculitis was sonographically characterized by a circumferential, hypoechogenic wall thickening. According to the CDS findings, patients were categorized into patients with involvement of the subclavian/axillary arteries only (group A1, n = 17), patients with involvement of both the subclavian/axillary arteries and the temporal arteries (group A2, n = 9), and patients with isolated cranial GCA (group B, n = 17). Data on recurrences, corticosteroid doses, and steroid-sparing agents were extracted from the medical records. Treatment response over time was analyzed by Kaplan-Meier curves with log-rank testing. Results: The mean follow-up time was 25.4 months and did not differ between groups (P = .4). Patients in group A1 were significantly younger than patients in groups A2 and B (P < .01). The interval between symptom onset and diagnosis was significantly longer in groups A1 and A2 compared with group B (P < .01). The number of recurrences per month was significantly higher in group A2 compared with group A1 and group B (A1, 0.07; A2, 0.13; B, 0.03; P < .01). Whereas there were no significant differences in the mean time until a daily prednisolone dose <10 mg was reached, patients in group A2 more frequently required steroid-sparing agents (A1, 24%; A2, 56%; B, 24%; P = .04). Conclusions: Extensive vascular involvement of both the temporal and subclavian/axillary arteries, as depicted by CDS, may be associated with a poor treatment response in GCA.
引用
收藏
页码:1285 / 1291
页数:7
相关论文
共 50 条
  • [21] Subclavian artery involvement in patients with giant cell arteritis: do we need a modified Halo Score?
    Molina Collada, Juan
    Martinez-Barrio, Julia
    Serrano-Benavente, Belen
    Castrejon, Isabel
    Nieto-Gonzalez, Juan Carlos
    Caballero Motta, Liz Rocio
    Trives Folguera, Laura
    Alvaro-Gracia, Jose Maria
    CLINICAL RHEUMATOLOGY, 2021, 40 (07) : 2821 - 2827
  • [22] Subclavian artery involvement in patients with giant cell arteritis: do we need a modified Halo Score?
    Juan Molina Collada
    Julia Martínez-Barrio
    Belén Serrano-Benavente
    Isabel Castrejón
    Juan Carlos Nieto-González
    Liz Rocío Caballero Motta
    Laura Trives Folguera
    José María Álvaro-Gracia
    Clinical Rheumatology, 2021, 40 : 2821 - 2827
  • [23] Listen to the Axillary Artery Diagnosis of Occult Giant Cell Arteritis
    Czihal, Michael
    Brendel, Thomas
    Seibold, Christa
    Reincke, Martin
    Hoffmann, Ulrich
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2011, 17 (04) : 214 - 215
  • [24] Giant cell arteritis: Advanced sonography detects involvement of large vessels
    Lorenz, Judith
    AKTUELLE RHEUMATOLOGIE, 2023, 48 (06) : 385 - 386
  • [25] Leg artery involvement in giant cell arteritis.
    Tazi, Z
    Cacoub, P
    Cheysson, D
    Godeau, P
    Piette, JC
    REVUE DE MEDECINE INTERNE, 1997, 18 (08): : 638 - 641
  • [26] The Usefullness of Subclavian Artery Ultrasound Assessment in Giant Cell Arteritis Evaluation
    Oshinsky, Charles
    Bays, Alison M. M.
    Sacksen, Ingeborg
    Jernberg, Elizabeth
    Zierler, R. Eugene
    Pollock, P. Scott
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2023, 29 (01) : 43 - 46
  • [27] AXILLARY ARTERIES ULTRASOUND IN THE DIAGNOSIS OF GIANT CELL ARTERITIS WITH PREDOMINANTLY CRANIAL SYMPTOMS
    Martinho, J.
    Sousa Bandeira, M. J.
    James, L.
    Verdiyeva, A.
    Fontes, T.
    Lopes, A. R.
    Khmelinskii, N.
    Luqmani, R.
    Ponte, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 761 - 761
  • [28] A FATAL CASE OF GIANT-CELL ARTERITIS (TEMPORAL OR CRANIAL ARTERITIS) WITH OCULAR INVOLVEMENT
    SPENCER, WH
    HOYT, WF
    ARCHIVES OF OPHTHALMOLOGY, 1960, 64 (06) : 862 - 867
  • [29] Vascular involvement in patients with giant cell arteritis determined by duplex sonography of 2x11 arterial regions
    Aschwanden, Markus
    Kesten, Friederike
    Stern, Martin
    Thalhammer, Christoph
    Walker, Ulrich A.
    Tyndall, Alan
    Jaeger, Kurt A.
    Hess, Christoph
    Daikeler, Thomas
    ANNALS OF THE RHEUMATIC DISEASES, 2010, 69 (07) : 1356 - 1359
  • [30] Color duplex ultrasonography in large-vessel giant cell arteritis
    Schmidt, WA
    Kraft, HE
    Borkowski, A
    Gromnica-Ihle, EJ
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 1999, 28 (06) : 374 - 376